• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sera from middle-aged adults vaccinated annually with seasonal influenza vaccines cross-neutralize some potential pandemic influenza viruses

tetano

Editor, Senior Moderator
J Infect Dis. 2015 Aug 4. pii: jiv407. [Epub ahead of print]
[h=1]Sera from middle-aged adults vaccinated annually with seasonal influenza vaccines cross-neutralize some potential pandemic influenza viruses.[/h] Wang W[SUP]1[/SUP], Facundo EA[SUP]1[/SUP], Chen Q[SUP]1[/SUP], Anderson CM[SUP]2[/SUP], Scott D[SUP]2[/SUP], Vassell R[SUP]1[/SUP], Weiss CD[SUP]3[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] We examined sera from adults ages 48-64 who received multiple seasonal influenza vaccines from 2004-2009 for cross-neutralizing antibodies to potential pandemic strains. Using pseudoviruses bearing various hemagglutinins (HA-pseudoviruses), we found serum neutralization titers (> 160) in 100% against A/Japan/305/1957 (H2N2), 53% against A/Hong Kong/1073/99 (H9N2), 56% against the H3N2 variant A/Indiana/08/11 (H3N2v), 11% against A/Hong Kong/G9/97 (H9N2), and 36% A/chicken/Hong Kong/SF4/01 (H6N1). None had titers>160 to A/Shanghai/2/13 (H7N9) or A/Netherlands/219/03 (H7N7). 36%-0% had neutralization titers to various H5N1 strains. Titers to H9, H6 and H5 HA-pseudoviruses correlated with each other, but not with H3N2v, suggesting group-specific cross-neutralization.
Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.


PMID: 26243315 [PubMed - as supplied by publisher]
 
Back
Top Bottom